Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view).
BSX last changed hands at $44.77 (up 0.33%). At $64.87B, Boston Scientific is ranked #253 by size among the 300 stocks on BeStock.
It is close to the bottom of its 52-week range ($42.20 to $105.65), 57.6% under the high. Holders are behind 54.3% over twelve months, but up 0.7% across the last three months.
On the chart it has slipped under both the 50-day ($46.87) and 200-day ($63.47) moving averages; RSI is 46, and the last 30 sessions moved at roughly 40% annualized volatility.
For the quarter ended Jun 2026 it reported $5.44B in revenue, up 7.5% from a year earlier, with $905.00M of net profit (a 17.5% margin).
Buyers are paying 18.1 times trailing earnings, 74% below its five-year average of 69.0. The median for its industry group is 23.9.
21 analysts follow the stock and the average call is "buy". The mean target, $60.11, sits 34.3% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Boston Scientific makes catheters, stents, heart-rhythm devices and other tools used in minimally invasive procedures.
What tends to move it. Growth in its electrophysiology and Watchman heart devices is the main story, along with procedure volumes at hospitals.
Written by hand by the BeStock desk and revised when a business changes. See how we work. Spot something out of date? Tell us.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -1.7% | Bearish |
| Price vs 50-day average | -4.5% | Bearish |
| Price vs 200-day average | -29.5% | Bearish |
| 50-day vs 200-day | 50d below 200d | Bearish |
| RSI (14) | 46.3 | Bearish |
| MACD (12,26,9) | -1.07 | Bearish |
| Bollinger band position | 40% | Bearish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Sep 24, 2026 2:00 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 300 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A row is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 0th percentile, 5-year average 69.0x
#1325 of 2977 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 1st percentile, 5-year average 4.7x
#3272 of 5304 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 6.2x
#3000 of 5143 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: −$265.53M (6 inflow days, 14 outflow days).
$44.77 is the latest print for BSX, a move of +0.33% against yesterday's close of $44.62. Today's low and high so far: $44.47 and $45.16.
Equity value comes to $64.87B at the current price. By that measure it is number 253 of the 300 names in our coverage.
Buyers pay 18.1 times the last twelve months of profit (EPS $1.94). Averaged over five years the multiple has been 69.0, and today's level ranks in the 0th percentile of its own history.
The year's floor is $42.20 and the ceiling $105.65. Shares are 57.6% away from that ceiling.
Our data shows no dividend paid by Boston Scientific over the trailing twelve months.
Of 21 analysts, 90% say buy, 10% hold and 0% sell. Price targets average $60.11, with the most cautious at $50.00 and the most optimistic at $85.00.
Boston Scientific makes catheters, stents, heart-rhythm devices and other tools used in minimally invasive procedures.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.